New Mammo Enhance Heart Program to Enhance Dual Screening for Breast Cancer and Cardiovascular Disease
The Mammo Enhance Heart program combines AI detection of breast arterial calcification (BAC) on screening mammography and subsequent follow-up with a local network of cardiologists.
Emphasizing detection of breast arterial calcification (BAC) on screening mammograms, appropriate risk stratification for cardiovascular disease and timely follow-up with cardiologists, Radiology Partners has launched the Mammo Enhance Heart program.
In addition to utilizing FDA-cleared artificial intelligence (AI) to detect BAC on mammograms, Radiology Partners said the Mammo Enhance Heart program incorporates an internally developed scoring system for cardiovascular risk and facilitates follow-up with cardiology specialists.
In addition to utilizing FDA-cleared artificial intelligence (AI) to detect BAC on mammograms, Radiology Partners said the Mammo Enhance Heart program incorporates an internally developed scoring system for cardiovascular risk and facilitates follow-up with cardiology specialists. (Images courtesy of Radiology Partners.)
Noting that women with BAC on mammograms are over 50 percent more likely to develop heart disease or stroke, Arthy Saravanan, M.D. says the Mammo Enhance Heart program may go a long way toward promoting preventive health care.
“Integrating this screening into routine mammogram appointments allows providers to monitor changes over timewithout additional exams,” noted Dr. Saravanan, a breast radiologist and associate chief medical officer for Radiology Partners. “With this continuous evaluation, patients are more in tune with their risk factors and overall health, making this a powerful program for managing long-term health.”
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
